379 results in Exploration of Targeted Anti-tumor Therapy
Most Viewed
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Retracted: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
Rolla Al-Shalabi ... Nozlena Abdul Samad
Published: July 27, 2025 Explor Target Antitumor Ther. 2025;6:1002332
Open Access
Review
Conceptual breakthroughs of the long noncoding RNA functional system and its endogenous regulatory role in the cancerous regime
Anyou Wang
Published: February 27, 2024 Explor Target Antitumor Ther. 2024;5:170–186
Open Access
Short Communication
Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomas
Indraja D. Dev ... Archi Agrawal
Published: October 31, 2024 Explor Target Antitumor Ther. 2024;5:1289–1296
Open Access
Case Report
Upper tract urothelial cancer (UTUC) genomic profiling and correlation regarding benefit of platinum-based chemotherapy
Min Woo Hwang ... Jeanny B. Aragon-Ching
Published: October 17, 2024 Explor Target Antitumor Ther. 2024;5:1261–1270
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Case Report
Immune checkpoint inhibitor-induced cholangitis—a three-case series
Simon Gray ... Anna Olsson-Brown
Published: July 19, 2024 Explor Target Antitumor Ther. 2024;5:818–825
Open Access
Original Article
Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer
Abhishek Mahajan ... Kumar Prabhash
Published: August 30, 2023 Explor Target Antitumor Ther. 2023;4:657–668
This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
Open Access
Original Article
Artificial intelligence fusion for predicting survival of rectal cancer patients using immunohistochemical expression of Ras homolog family member B in biopsy
Tuan D. Pham ... Xiao-Feng Sun
Published: February 07, 2023 Explor Target Antitumor Ther. 2023;4:1–16
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Review
Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Mariam Rojas ... Joan Maurel
Published: September 23, 2025 Explor Target Antitumor Ther. 2025;6:1002337
This article belongs to the special issue Predictive and Prognostic Biomarkers in Cancer: Towards the Precision Medicine Era
Open Access
Case Report
Oligometastatic esophageal cancer cured by systemic therapy combined with radiotherapy to primary tumor and metastasis (metastasis-directed therapy)—small case series
Mohan Hingorani, Hannah Stubley
Published: July 26, 2024 Explor Target Antitumor Ther. 2024;5:921–930
Open Access
Original Article
The effect of iron on the expression levels of calcium related gene in cisplatin resistant epithelial ovarian cancer cells
Bahire Kucukkaya ... Leman Yalcintepe
Published: August 30, 2021 Explor Target Antitumor Ther. 2021;2:309–322
Open Access
Original Article
Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors
Ibrahim H. Kankia ... Yusuf Y. Deeni
Published: April 30, 2021 Explor Target Antitumor Ther. 2021;2:187–203
Open Access
Review
Coronavirus disease 2019 and lung cancer: where are we?
Abrahams Ocanto ... Felipe Couñago
Published: October 30, 2023 Explor Target Antitumor Ther. 2023;4:1082–1094
This article belongs to the special issue COVID-19 and Cancer
Open Access
Case Report
Improving single nucleotide polymorphisms genotyping accuracy for dihydropyrimidine dehydrogenase testing in pharmacogenetics
Annalaura Montella ... Mario Capasso
Published: April 24, 2024 Explor Target Antitumor Ther. 2024;5:374–383
This article belongs to the special issue Molecular Diagnosis and Personalized Therapy of Cancer
Open Access
Case Report
Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS-mutated metastatic intrahepatic cholangiocarcinoma: a case report
Aram A. Musaelyan ... Sergey V. Orlov
Published: June 28, 2024 Explor Target Antitumor Ther. 2024;5:780–788
Open Access
Original Article
Cola rostrata K. Schum. constituents induce cytotoxicity through reactive oxygen species generation and mitochondrial membrane depolarisation
Babatunde E. Ajayi ... Amos A. Fatokun
Published: December 28, 2023 Explor Target Antitumor Ther. 2023;4:1328–1344
This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents
Open Access
Original Article
N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas
Feng Yuan ... Chiyuan Ma
Published: September 30, 2022 Explor Target Antitumor Ther. 2022;3:553–569
This article belongs to the special issue Theranostic Frontiers in Neuro-Oncology
Open Access
Review
Combination of the PARPi and ARSi in advanced castration resistant prostate cancer: a review of the recent phase III trials
Martina Panebianco ... Mario Rosario D’Andrea
Published: August 02, 2024 Explor Target Antitumor Ther. 2024;5:997–1010
Open Access
Review
The DNA methylation landscape of musculoskeletal sarcomas
Mariana Chantre-Justino, Walter Meohas
Published: May 26, 2025 Explor Target Antitumor Ther. 2025;6:1002319
Open Access
Review
GPCRs as targets for flavonoids in cancer cells: new options for intervention
Katrin Sak
Published: August 30, 2024 Explor Target Antitumor Ther. 2024;5:1155–1167
Open Access
Original Article
Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers
Rosa Falcone ... Gennaro Daniele
Published: August 31, 2023 Explor Target Antitumor Ther. 2023;4:716–726
Previous